PF-06821497 Uses, Dosage, Side Effects and more
PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma).
| Trade Name | PF-06821497 |
| Generic | PF-06821497 |
| Type | |
| Formula | C22H24Cl2N2O5 |
| Weight | Average: 467.34 Monoisotopic: 466.1062273 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
